Chronic Pain
Conditions
Interventions
This is a randomized, double-blind, parallel, sham-controlled clinical trial that will follow the recommendations of the Consolidated Standards of Reporting Trials (CONSORT). The sample will consist o
experimental group). For the intervention process, women will be asked not to undergo physical therapy treatment for their condition during the study, not to participate in other intervention studies,
E02.331.750
Sponsors
Maternidade Escola Assis Chateaubriand da Universidade Federal do Ceará - MEAC/UFC
Universidade federal do Ceará
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Female participants; with a clinical diagnosis of Chronic Pelvic Pain that persists for at least six months; aged eighteen to forty-five years; with a score greater than or equal to three on the Numerical Pain Scale
Exclusion criteria
Exclusion criteria: Pregnant or lactating women will be excluded; those with cognitive dysfunction; those with diagnosed central neurological diseases; those with diagnosed but untreated psychiatric diseases; those with oncological diseases; those with metal implants and or pacemakers; those with a history of epilepsy and or seizures; those with chronic musculoskeletal conditions that overlap with Chronic Pelvic Pain; those with chronic skin diseases and or scalp lesions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the reduction in pain intensity using the Numerical Pain Scale applied at the beginning and end of the study | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the improvement in Pressure Pain Threshold through the algometer test applied at the beginning of the study and at the end of the study;To assess the improvement in functioning using the World Health Organization Disability Assessment Schedule 2.0 questionnaire applied at the beginning and end of the study ;To assess the improvement of kinesiophobia through the Scale for Kinesiophobia questionnaire applied at the beginning of the study and at the end of the study ;To assess the improvement in quality of life through the 12-Item Short-Form Health Survey questionnaire applied at the beginning of the study and at the end of the study;To assess the reduction of presenteeism using the Stanford Presenteeism Scale questionnaire applied at the beginning and end of the study;To assess patients' global perception of change using the Patient's Global Impression of Change instrument applied in the intermediate phase and at the end of the study;To assess patients' depressive symptoms using the Patient Health Quality-9 instrument at the beginning and end of the study | — |
Countries
Brazil
Contacts
Public ContactLiliane Barreto
Universidade federal do Ceará
Outcome results
None listed